ABCB4 p.Ser224Pro
Predicted by SNAP2: | A: N (78%), C: N (72%), D: N (53%), E: D (59%), F: N (57%), G: N (61%), H: N (53%), I: N (57%), K: D (63%), L: N (57%), M: N (61%), N: N (61%), P: D (63%), Q: D (53%), R: D (59%), T: N (97%), V: N (61%), W: D (66%), Y: D (59%), |
Predicted by PROVEAN: | A: N, C: D, D: D, E: D, F: D, G: D, H: D, I: D, K: D, L: D, M: D, N: D, P: D, Q: D, R: D, T: D, V: D, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Mutational analysis of the P-glycoprotein first in... Biochemistry. 1998 Mar 10;37(10):3337-50. Kwan T, Gros P
Mutational analysis of the P-glycoprotein first intracellular loop and flanking transmembrane domains.
Biochemistry. 1998 Mar 10;37(10):3337-50., 1998-03-10 [PMID:9521654]
Abstract [show]
The role of individual intracellular (IC) loops linking transmembrane (TM) domains in P-glycoprotein (P-gp) function remains largely unknown. The high degree of sequence conservation of these regions in the P-gp family and other ABC transporters suggests an important role in a common mechanism of action of these proteins. To gain insight into this problem, we have randomly mutagenized a portion of TM2, the entire IC1 loop, TM3, the entire extracellular loop (EC2), and part of TM4, and analyzed the effect of such mutations on P-gp function. Random mutagenesis was carried out using Taq DNA polymerase and dITP under conditions of low polymerase fidelity, and the mutagenized segments were reintroduced in the full length mdr3 cDNA by homologous recombination in the yeast Saccharomyces cerevisiae strain JPY201. The biological activity of mutant P-gp variants was analyzed in yeast by their ability to confer cellular resistance to the antifungal drug FK506 and the peptide ionophore valinomycin, and by their ability to complement the yeast Ste6 gene and restore mating in a yeast strain bearing a null mutation [Raymond, M., et al. (1992) Science 256, 232-4] at this locus. The analysis of 782 independent yeast transformants allowed the identification of 49 independent mutants bearing single amino acid substitutions in the mutagenized segment resulting in an altered P-gp function. The mutants could be phenotypically classified into two major groups, those that resulted in partial or complete overall loss of function and those that seemed to affect substrate specificity. Several of the mutants affecting overall activity mapped in IC1; in particular we identified a segment of four consecutive mutation sensitive residues (TRLT, positions 169-172) with such a phenotype. On the other hand, we identified a cluster of mutants affecting substrate specificity within the short EC2 segment and in the adjacent portion of the neighboring TM4 domain. Expression and partial purification of a representative subset of these mutants showed that in all but two cases, loss of function was associated with loss of drug-induced ATPase activity of P-gp. Therefore, it appears that TM domains, IC and EC loops, are structurally and functionally tightly coupled in the process of drug stimulatable ATPase characteristic of P-gp.
Comments [show]
None has been submitted yet.
No. Sentence Comment
194 Such mutants showed near wild-type transport Table 1: Summary of Mutations Identifieda TM2 IC1 TM3 EC2 TM4 Q128H R138H F159I S176P G187E R206L L210I Q128R Q139H V161E K177I A192T W208G T211P L134P Q139P H162R N179S F200L K209E V213A A136V Q139R T169I E180G F204S I214L Q145H R170L G181R I214T F147L L171P G183D S224P F148S T172P D184N E155G D174G E155K S176F a Summary of the mutations identified in the current screen together with their position within the predicted secondary structure of P-glycoprotein, with respect to the second (TM2), third (TM3), and fourth (TM4) predicted transmembrane domains together with the first intracellular (IC1) and second extracellular loop (EC2).
X
ABCB4 p.Ser224Pro 9521654:194:311
status: NEW50 Mutants Q128R, Q139H, F147L, E155L, T169I, T172P, G181R, A192T, W208G, L210I, and S224P were introduced into pHILD2mdr3 by the direct replacement of an internal 1.6 kb Afl II/Sma I mdr3 cDNA subfragment (pst 170 to 1764) by the corresponding mutated mdr3 cDNA segment in pVTM3IC1.
X
ABCB4 p.Ser224Pro 9521654:50:82
status: NEW188 Group 1 comprised 17 mutants, including Q128R, L134P, F147L, F148S, F159I, V161E, H162R, T169I, R170L, L171P, T172P, G181R, G187E, W208G, K209E, I214L, and S224P.
X
ABCB4 p.Ser224Pro 9521654:188:156
status: NEW207 This was particularly important in the case of Mdr3 mutants such as Q128R, L134P, V161E, R170L, L171P, G181R, G187E, and S224P that show complete loss of function in the three assays conducted.
X
ABCB4 p.Ser224Pro 9521654:207:121
status: NEW223 The P. pastoris expression system was used to express and functionally characterize a representative subset of 11 loss of function mutants mapping to the various structural domains targeted for random mutagenesis: Q128R, Q139H, F147L, E155K, T169I, T172P, G181R, A192T, W208G, L210I, and S224P.
X
ABCB4 p.Ser224Pro 9521654:223:288
status: NEW253 The remaining mutants (Q128R, Q139H, E155K, T169I, G181R, L210I, and S224P) had no significant level of ATP hydrolysis above background (pHILD2 negative control).
X
ABCB4 p.Ser224Pro 9521654:253:69
status: NEW257 Km values could not be determined for the remaining mutants (Q128R, Q139H, E155K, T169I, G181R, L210I, S224P) which displayed no significant drug-stimulated ATP hydrolysis above background.
X
ABCB4 p.Ser224Pro 9521654:257:103
status: NEW270 Table 2: ATPase Activities of P-gp Mutantsa no drug, Vmax Vmax VRP stimulation KM pHILD2 0.037 0.031 0.8 ND WT 0.028 0.078 2.8 0.6 Q128R 0.022 0.034 1.6 ND Q139H 0.023 0.028 1.3 ND F147L 0.039 0.081 2.0 0.8 E155K 0.033 0.034 1.0 ND T169I 0.014 0.017 1.2 ND T172P 0.032 0.056 1.7 0.9 G181R 0.032 0.033 1.1 ND A192T 0.035 0.052 1.5 0.6 W208G 0.046 0.100 2.2 0.9 L210I 0.042 0.046 1.1 ND S224P 0.032 0.032 1.0 ND a Summary of kinetic analysis performed on a representative sample of mutants.
X
ABCB4 p.Ser224Pro 9521654:270:385
status: NEW328 This group consisted of mutants in TM2 (Q128R), IC1 (Q139H, F147L, E155K, T169I, T172P, G181R), TM3 (A192T), EC2 (W208G), and TM4 (L210I, S224P).
X
ABCB4 p.Ser224Pro 9521654:328:138
status: NEW